NCT03054220View on ClinicalTrials.gov

Impact of Genetic Polymorphism on Drug-Drug Interactions Involving CYP2D6

NACompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Healthy
Interventions
DRUG

Dextromethorphan 5 MG

DRUG

Tramadol 10 mg

DRUG

Duloxetine 60mg

DRUG

Paroxetine 20 mg

All Listed Sponsors
lead

Jules Desmeules

OTHER

NCT03054220 - Impact of Genetic Polymorphism on Drug-Drug Interactions Involving CYP2D6 | Biotech Hunter | Biotech Hunter